[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.142.229. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1996

CosmeceuticalsA Proposal for Rational Definition, Evaluation, and Regulation

Author Affiliations

Leiden, the Netherlands; Department of Dermatology Boston University School of Medicine 80 E Concord St Boston, MA 02118-2394; Department of Dermatology, University Medical Center, University of Leiden.

Arch Dermatol. 1996;132(3):337-340. doi:10.1001/archderm.1996.03890270113017
Abstract

The WORD cosmeceuticals was coined nearly 10 years ago1 by Albert M. Kligman, MD, PhD, professor emeritus of dermatology, the University of Pennsylvania, Philadelphia, a man who during his career has repeatedly crystalized issues and opportunities within dermatology. The immediate acceptance and subsequent widespread usage of this term and its variants speak to the legitimacy of a product category intermediate between cosmetics and pharmaceuticals.2,3 Nevertheless, regulatory agencies have not yet formally recognized cosmeceuticals, despite a rapid proliferation of "cosmetic" products that have a documented and intended pharmaceutical activity and a dermatologic knowledge base that renders obsolete earlier distinctions between cosmetics and drugs. The following paragraphs review current product realities in the hope of motivating responsible persons and organizations in academe, industry, and government to confront the need for rational definitions and regulatory procedures related to skin care products in the 21st century. We include a general proposal as

First Page Preview View Large
First page PDF preview
First page PDF preview
×